Research progress of capecitabine combined chemotherapy with biweekly scheme
- VernacularTitle:卡培他滨联合化疗双周方案研究进展
- Author:
Shoudong MA
;
Guogui SUN
;
Honggang ZHANG
- Keywords:
capecitabine;
chemotherapy;
biweekly scheme
- From:
Basic & Clinical Medicine
2017;37(6):884-888
- CountryChina
- Language:Chinese
-
Abstract:
As an oral chemotherapy drug, capecitabine is safe, effective and easy to use, has been widely used in the treatment of esophageal cancer, gastric cancer, colorectal cancer, breast cancer, ovarian cancer and other solid tumor.The chemotherapy scheme is mainly for 3 weeks, each cycle of capecitabine for 14 days, and 7 days off.As a modification to conventional chemotherapy, the biweekly scheme with capecitabine showed low toxicity and well tolerated by patients, short hospitalization time and other characteristics, it is worth of application in clinical.
